- Raised $11.1M Series A led by Dr. Reddy's Laboratories, Nov 2023
- Raised $2.3M Seed round led by NFX Capital, Aug 2021
- Raised Seed Extension led by OurCrowd, Sep 2023
About
Edity Therapeutics is a biotechnology company based in Rehovot, Israel, founded in 2019 (some sources say 2020). The company has developed a proprietary platform that utilizes immune cells to deliver therapeutic proteins directly to the cytoplasm of diseased cells. This technology aims to reprogram cells and tissues back to health by enabling intracellular modulation through mechanisms like protein replacement, target modulation, genetic correction, and protein gain-of-function. Edity is focused on developing therapies for various indications, including oncology and genetic diseases, with programs also in development for regeneration and longevity. The company's approach leverages advanced AI algorithms to engineer therapeutic proteins and optimize them for targeted delivery through the immune system. Edity is particularly focused on addressing challenges in treating solid tumors with cell therapies.
Funding history · 3 rounds · $13.4M total
Headcount over time
Q&A
- What is Edity Therapeutics' primary focus?
- Edity Therapeutics is an Israeli biotechnology company developing a platform that harnesses the immune system to deliver therapeutic proteins directly to diseased cells, aiming to reprogram cells and tissues back to health.
- When was Edity Therapeutics founded?
- Edity Therapeutics was founded in October 2019.
- How many employees does Edity Therapeutics currently have?
- Edity Therapeutics has 11-50 employees.
- What is the total amount of funding Edity Therapeutics has raised to date?
- Edity Therapeutics has raised a total of $13,632,300 USD.
- When did Edity Therapeutics complete its Series A funding round?
- Edity Therapeutics completed its Series A funding round in December 2023, raising $11,100,000 USD.
- Did Edity Therapeutics engage in any equity crowdfunding?
- Yes, Edity Therapeutics completed an equity crowdfunding round in October 2023, raising $252,300 USD.
- What was Edity Therapeutics' first funding round?
- Edity Therapeutics' first funding round was a Seed round in September 2021, which raised $2,280,000 USD.
- Which company did Edity Therapeutics announce a strategic collaboration with in January 2024?
- In January 2024, Edity Therapeutics announced a strategic collaboration with Dr. Reddy's Laboratories to advance a novel cell therapy approach using Edity's proprietary delivery platform.
- Who are the founders of Edity Therapeutics?
- The founders of Edity Therapeutics are Michal Golan-Mashiach (CEO), Eyal Kolka (Co-Founder and Chairman), and Yoav Manaster (Co-founder).
Team · 3
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | edity-tx.com |
|---|---|
| linkedin.com/company/67330457 | |
| YouTube | youtube.com/@editytherapeuticsltd.388 |
Identifiers & details
| Legal name | Edity Therapeutics Ltd. |
|---|---|
| Founded | 2019-10 |
| Employees (exact) | 23 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | edity-tx.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516095270 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-10-22 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2026 |
| Active charges / liens | 0 |
| Registry events | 5 — annual_report (3), violation (1), people (1) |
| Registered address | פלאוט מנחם 10 רחובות |
Recent registry events
| Date | Event |
|---|---|
| 2026-06-25 | דו~ח שנתי-הגדלת הון |
| 2026-06-25 | דו~ח שנתי-הקצאת מניות |
| 2026-06-25 | עדכון הפרה |
| 2026-06-25 | דו~ח שנתי-עדכון כתובת |
| 2026-03-19 | עדכון בעלי תפקידים |